Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.71 +0.12 (+1.58%)
As of: Oct 21, 2026 · 11:23 AM EDT

Eupraxia Pharmaceuticals (EPRX) Tax Provisions (2024 - 2026)

Updated

Eupraxia Pharmaceuticals (EPRX) recorded Tax Provisions of -$30,381 in the quarter ended Jun 30, 2026, compared with -$5,581 a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Tax Provisions (2024 - 2026) Analysis & Trends

On a TTM basis, Eupraxia Pharmaceuticals' Tax Provisions came in at -$52,661 as of Jun 30, 2026; for the year ended Dec 31, 2025, it was -$19,091.

  • Across earlier years, Tax Provisions came in at -$1,804 in the year ended Dec 31, 2024 and -$36,423 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,131.24 Bn 1,099.82 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 614.68 Bn 533.21 Bn 17.26 Bn 1.21 Bn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn 662.00 Mn
4 Merck 368.01 Bn 322.38 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 298.43 Bn 262.42 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn 291.00 Mn
7 Amgen 236.03 Bn 191.43 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 190.92 Bn 165.12 Bn 6.22 Bn 242.00 Mn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn -407.00 Mn
10 Eupraxia Pharmaceuticals 306.24 Mn -135.82 Mn - -30,381.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -30,381.00
Mar 31, 2026 -13,905.00
Dec 31, 2025 26,843.00
Sep 30, 2025 623.00
Jun 30, 2025 -5,581.00
Mar 31, 2025 -2,794.00
Jun 30, 2024 5,000.00
Mar 31, 2024 -5,000.00
API Access

Eupraxia Pharmaceuticals Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=EPRX&period=max&api_key=YOUR_API_KEY